Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03205111
Other study ID # Office Hysteroscope
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 29, 2017
Last updated June 29, 2017
Start date July 2017
Est. completion date July 2018

Study information

Verified date June 2017
Source Assiut University
Contact Ahmed Z. Fahmi
Phone +201020440944
Email ahmed_zaki_1985@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to photographically characterize the endometrium in patients presenting with abnormal uterine bleeding at age group from 20 to 45 years old.

and compare dilatation and curettage with hysteroscopy in obtaining an accurate diagnosis of the etiology of abnormal uterine bleeding.


Description:

Menstrual dysfunction is the cause of discomfort and disturbed healthy lifestyle. Abnormal uterine bleeding (AUB) is considered as a common problem in premenopausal women. AUB is defined as bleeding from the uterine that is abnormal in volume, regularity, and/or timing.

There are various diagnostic modalities available in the market, ranging from traditional dilation and curettage (D&C), transvaginal sonography, hysteroscopy and saline infusion sonography. Dilation and curettage is the most widely used simple day care procedure for histological evaluation of the endometrial. It was once considered as the gold standard of investigating women with AUB.

Office hysteroscopy is a very useful technique for diagnosis and treatment of uterine pathology in an office-based environment. It is directly related to the technological explosion, which during the last years has further evolved and given us the opportunity to perform hysteroscopy without providing general anesthesia or sedation to the patients, due to the narrow width of the latest generation hysteroscopes. Hysteroscopic inspection of uterine cavity is a simple and well accepted method. The direct real time visualization, real-color, hydrated, well-illuminated, and augmented vision of the uterine cavity make this diagnostic tool very accurate to detect minute focal endometrial pathology and small lesions and helping us to take well guided direct biopsies.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date July 2018
Est. primary completion date June 2018
Accepts healthy volunteers
Gender Female
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria:

- Perimenopausal women complaining of abnormal uterine bleeding.

Exclusion Criteria:

- Active pelvic infections

- Medical disorders

- Bleeding tendency

- Hormonal treatment

- Pregnancy

- Contraceptive treatment

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Bennett AR, Gray SH. What to do when she's bleeding through: the recognition, evaluation, and management of abnormal uterine bleeding in adolescents. Curr Opin Pediatr. 2014 Aug;26(4):413-9. doi: 10.1097/MOP.0000000000000121. Review. — View Citation

Saadia A, Mubarik A, Zubair A, Jamal S, Zafar A. Diagnostic accuracy of endometrial curettage in endometrial pathology. J Ayub Med Coll Abbottabad. 2011 Jan-Mar;23(1):129-31. — View Citation

Zhu HL, Liang XD, Wang JL, Cui H, Wei LH. Hysteroscopy and directed biopsy in the diagnosis of endometrial carcinoma. Chin Med J (Engl). 2010 Dec;123(24):3524-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Hysteroscopic assessment of endometrial pathology Patterns of endometrial pathology after histopathological examination of the curretings in patients with abnormal uterine bleeding 7 days
See also
  Status Clinical Trial Phase
Completed NCT01461824 - Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects Phase 3
Recruiting NCT05304442 - IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department Phase 3
Enrolling by invitation NCT05089721 - Questionnaire for Obstetricians and Anesthesiologist
Completed NCT01992718 - What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Early Phase 1
Completed NCT00114088 - Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Phase 3
Recruiting NCT04209036 - Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?
Recruiting NCT06219538 - DAISY Uterine Drain Device Evaluation N/A
Completed NCT03075358 - Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial Phase 3
Completed NCT02705222 - Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women N/A
Completed NCT05783479 - Pharmacological Preparation of the Cervix for Hysteroscopy N/A
Recruiting NCT04766073 - Surgical Incision Closure Method to Prevent Niche Formation After Cesarean Section- Randomized Controlled Trial N/A
Active, not recruiting NCT04434066 - Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy N/A
Recruiting NCT04637022 - 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial
Recruiting NCT06106633 - Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization N/A
Completed NCT05483348 - Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection
Terminated NCT04676061 - Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™ Phase 4
Completed NCT04710017 - Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding N/A
Not yet recruiting NCT05224726 - Platelet Rich Plasma for Uterine Scar N/A
Recruiting NCT06308172 - Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial N/A
Recruiting NCT03264781 - The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users Phase 1/Phase 2